Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

… And Joins With SAFC To Make Conjugates

by Ann M. Thayer
October 6, 2014 | A version of this story appeared in Volume 92, Issue 40

[+]Enlarge
Credit: SAFC
SAFC makes antibody-drug conjugates at this facility in St. Louis.
A worker at Sigma-Aldrich’s St. Louis ADC facility.
Credit: SAFC
SAFC makes antibody-drug conjugates at this facility in St. Louis.

Sigma-Aldrich’s SAFC custom manufacturing business will collaborate with Baxter’s BioPharma Solutions unit to produce antibody-drug conjugates. SAFC will contribute capability for manufacturing drug linkers and conducting conjugations, while Baxter will provide sterile drug product filling and finishing services. Together, the companies hope to provide customers with end-to-end contract manufacturing in which a bulk drug substance conjugated by SAFC is transferred to Baxter for final steps including filling, regulatory testing, and packaging.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.